During tumour development it has often been reported that diminished IFN responsiveness co-evolves as a frequent genetic defect and that tumours evade their immune control by mutations frequently affecting genes involved in JAK/STAT signalling [183,184,185,186]. This evidence concerns the gene IFNA1 and neoplasm.